Company: ATIIU
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001437749-25-002910
Chunk: 4

Company: Archimedes Tech SPAC Partners II Co.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 4
---
 to purchase an aggregate of 765,000 units, or “private units” (515,000 private units by the sponsor and 250,000 private units by BTIG), or 840,000 private units (530,000 private units by the sponsor and 310,000 private units by BTIG) if the underwriters’ option to purchase additional units is exercised in full, at a price of $10.00 per unit ($7,650,000 in the aggregate, or $8,400,000 in the aggregate if the underwriters’ option to purchase additional units is exercised in full) in a private placement that will close simultaneously with the closing of this offering. Each private unit will consist of one ordinary share and one-half of one redeemable warrant. We refer to the shares included in the private units throughout this prospectus as the “private shares” and the warrants included in the private units as the “private warrants.” The private units are identical to the units sold in this offering, subject to certain limited exceptions as described in this prospectus. The private warrants will be identical to the warrants underlying the units being offered by this prospectus. For so long as they are held by BTIG or its affiliates or associated persons, the private warrants will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA rules.

Our sponsor currently holds 5,750,000 ordinary shares (which were purchased for $25,000 and which we refer to as “founder shares”), up to 750,000 of which are subject to forfeiture by our sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. Because our sponsor acquired the founder shares at a nominal price, our public shareholders will incur an immediate and substantial dilution upon the closing of this offering, assuming no value is ascribed to the warrants included in the units. See“Summary–Our Acquisition Process,”“Summary–Private Placements,”“Summary–The Offering–Founder Shares,”“Risk Factors — General Risks — Our sponsor paid a nominal price for the founder shares and, accordingly, you will experience immediate and substantial dilution upon the purchase of our ordinary shares”and“Certain Relationship and Related Party Transactions”.

If we are unable to complete our initial business combination within the completion window, or by such earlier liquidation date as our board of directors may approve, the founder shares, private shares and private warrants will be worthless, except to the extent they receive liquidating distributions from assets